Choroidal Neovascularization

Contributing journals to this collection:
JAMA & Archives Journals

Citations 51-60 of 119 total displayed.

Past content

Commentaries
Inhibitors of Ocular Neovascularization: Promises and Potential Problems

Peter van Wijngaarden; Douglas J. Coster; Keryn A. Williams
JAMA 2005; 293: 1509-1513. [Extract] [Full text] [PDF]  

Epidemiology
Health- and Vision-Related Quality of Life Among Patients With Ocular Histoplasmosis or Idiopathic Choroidal Neovascularization at Enrollment in a Randomized Trial of Submacular Surgery: Submacular Surgery Trials Report No. 5

Submacular Surgery Trials Research Group
Arch Ophthalmol 2005; 123: 78-88. [Abstract] [Full text] [PDF]  

Laboratory Sciences
Inhibition of Choroidal Neovascularization by a Peptide Inhibitor of the Urokinase Plasminogen Activator and Receptor System in a Mouse Model

Arup Das; Nathan Boyd; Terence R. Jones; Nicholas Talarico; Paul G. McGuire
Arch Ophthalmol 2004; 122: 1844-1849. [Abstract] [Full text] [PDF]  

Epidemiology
Patients’ Perceptions of the Value of Current Vision: Assessment of Preference Values Among Patients With Subfoveal Choroidal Neovascularization—The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6

Submacular Surgery Trials Research Group
Arch Ophthalmol 2004; 122: 1856-1867. [Abstract] [Full text] [PDF]  

Clinicopathologic Reports, Case Reports, and Small Case Series
Expression of LOX-1, an Oxidized Low-Density Lipoprotein Receptor, in Choroidal Neovascularization

Megumi Honjo; Tatsuya Sawamura; Junichi Hinagata; Kayo Nakamura; Nobuhito Sanada; Hidenobu Tanihara; Yoshihito Honda; Junichi Kiryu
Arch Ophthalmol 2004; 122: 1873-1876. [Extract] [Full text] [PDF]  

Clinical Trials
Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: I. Ophthalmic Findings From a Randomized Clinical Trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9

Submacular Surgery Trials Research Group
Arch Ophthalmol 2004; 122: 1597-1611. [Abstract] [Full text] [PDF]  

Clinical Trials
Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: II. Quality-of-Life Findings From a Randomized Clinical Trial: SST Group H Trial: SST Report No. 10

Submacular Surgery Trials Research Group
Arch Ophthalmol 2004; 122: 1616-1628. [Abstract] [Full text] [PDF]  

Clinical Sciences
Scanning Laser Entoptic Perimetry for the Detection of Age-Related Macular Degeneration

William R. Freeman; Mohamed El-Bradey; Daniel J. Plummer
Arch Ophthalmol 2004; 122: 1647-1651. [Abstract] [Full text] [PDF]  

Editorials
Now That We Have the Results of the Subretinal Surgery Trials, How Do We Manage the Patient?

Harry W. Flynn Jr; Ingrid U. Scott
Arch Ophthalmol 2004; 122: 1705-1706. [Extract] [Full text] [PDF]  

Laboratory Sciences
Histological Effect and Protein Expression in Subthreshold Transpupillary Thermotherapy in Rabbit Eyes

Yoshihiro Morimura; Annabelle A. Okada; Atsushi Hayashi; Sayuri Fujioka; Sumie Kawahara; Tetsuo Hida
Arch Ophthalmol 2004; 122: 1510-1515. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12